Year |
Citation |
Score |
2021 |
Mackenzie GA, Hill PC, Jeffries DJ, Ndiaye M, Sahito SM, Hossain I, Uchendu U, Ameh D, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Muhammad BS, Ahameefula E, ... ... Levine OS, et al. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance. The Lancet. Infectious Diseases. PMID 34280357 DOI: 10.1016/S1473-3099(20)30880-X |
0.316 |
|
2021 |
Mackenzie GA, Hill PC, Jeffries DJ, Ndiaye M, Sahito SM, Hossain I, Uchendu U, Ameh D, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Muhammad BS, Ahameefula E, ... ... Levine OS, et al. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance. The Lancet. Infectious Diseases. PMID 34280357 DOI: 10.1016/S1473-3099(20)30880-X |
0.316 |
|
2019 |
Hammitt LL, Etyang AO, Morpeth SC, Ojal J, Mutuku A, Mturi N, Moisi JC, Adetifa IM, Karani A, Akech DO, Otiende M, Bwanaali T, Wafula J, Mataza C, Mumbo E, ... ... Levine OS, et al. Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study. Lancet (London, England). PMID 31000194 DOI: 10.1016/S0140-6736(18)33005-8 |
0.639 |
|
2019 |
Silaba M, Ooko M, Bottomley C, Sande J, Benamore R, Park K, Ignas J, Maitland K, Mturi N, Makumi A, Otiende M, Kagwanja S, Safari S, Ochola V, Bwanaali T, ... ... Levine OS, et al. Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis. The Lancet. Global Health. 7: e337-e346. PMID 30784634 DOI: 10.1016/S2214-109X(18)30491-1 |
0.372 |
|
2017 |
Mackenzie GA, Hill PC, Sahito SM, Jeffries DJ, Hossain I, Bottomley C, Uchendu U, Ameh D, Ndiaye M, Osuorah CD, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Ahameefula E, ... ... Levine OS, et al. Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies. The Lancet. Infectious Diseases. PMID 28601421 DOI: 10.1016/S1473-3099(17)30321-3 |
0.322 |
|
2017 |
Gibson DG, Ochieng B, Kagucia EW, Were J, Hayford K, Moulton LH, Levine OS, Odhiambo F, O'Brien KL, Feikin DR. Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial. The Lancet. Global Health. 5: e428-e438. PMID 28288747 DOI: 10.1016/S2214-109X(17)30072-4 |
0.6 |
|
2016 |
Mackenzie GA, Hill PC, Jeffries DJ, Hossain I, Uchendu U, Ameh D, Ndiaye M, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Muhammad BS, Fombah AE, Saha D, Plumb I, ... ... Levine OS, et al. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study. The Lancet. Infectious Diseases. PMID 26897105 DOI: 10.1016/S1473-3099(16)00054-2 |
0.324 |
|
2014 |
Vasudevan L, Labrique AB, Mehra S, Wu L, Levine O, Feikin D, Klemm R, Christian P, West KP. Maternal determinants of timely vaccination coverage among infants in rural Bangladesh. Vaccine. 32: 5514-9. PMID 25132336 DOI: 10.1016/J.Vaccine.2014.06.092 |
0.377 |
|
2013 |
Hayford KT, Shomik MS, Al-Emran HM, Moss WJ, Bishai D, Levine OS. Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. Bmc Public Health. 13: 1211. PMID 24359402 DOI: 10.1186/1471-2458-13-1211 |
0.664 |
|
2013 |
Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. Plos Medicine. 10: e1001517. PMID 24086113 DOI: 10.1371/journal.pmed.1001517 |
0.316 |
|
2013 |
Hayford KT, Al-Emran HM, Moss WJ, Shomik MS, Bishai D, Levine OS. Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh. Journal of Virological Methods. 193: 512-8. PMID 23872267 DOI: 10.1016/J.Jviromet.2013.07.014 |
0.602 |
|
2012 |
Shearer JC, Walker DG, Risko N, Levine OS. The impact of new vaccine introduction on the coverage of existing vaccines: a cross-national, multivariable analysis. Vaccine. 30: 7582-7. PMID 23099327 DOI: 10.1016/j.vaccine.2012.10.036 |
0.314 |
|
2012 |
Mermond S, Zurawski V, D'Ortenzio E, Driscoll AJ, DeLuca AN, Deloria-Knoll M, Moïsi JC, Murdoch DR, Missotte I, Besson-Leaud L, Chevalier C, Debarnot V, Feray F, Noireterre S, Duparc B, ... ... Levine OS, et al. Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the Pneumonia Etiology Research for Child Health project. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S180-9. PMID 22403234 DOI: 10.1093/Cid/Cir1070 |
0.6 |
|
2012 |
Gilchrist SA, Nanni A, Levine O. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. American Journal of Public Health. 102: 596-605. PMID 22397339 DOI: 10.2105/Ajph.2011.300512 |
0.425 |
|
2012 |
Mackenzie GA, Plumb ID, Sambou S, Saha D, Uchendu U, Akinsola B, Ikumapayi UN, Baldeh I, Usuf E, Touray K, Jasseh M, Howie SR, Wattiaux A, Lee E, Knoll MD, ... Levine OS, et al. Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. Plos Medicine. 9: e1001161. PMID 22272192 DOI: 10.1371/Journal.Pmed.1001161 |
0.337 |
|
2011 |
Nakamura MM, Tasslimi A, Lieu TA, Levine O, Knoll MD, Russell LB, Sinha A. Cost effectiveness of child pneumococcal conjugate vaccination in middle-income countries. International Health. 3: 270-81. PMID 24038500 DOI: 10.1016/J.Inhe.2011.08.004 |
0.437 |
|
2011 |
Tasslimi A, Nakamura MM, Levine O, Knoll MD, Russell LB, Sinha A. Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countries. International Health. 3: 259-69. PMID 24038499 DOI: 10.1016/J.Inhe.2011.08.003 |
0.426 |
|
2011 |
Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, Wecker J, Duclos P, Greenwood B. The future of immunisation policy, implementation, and financing. Lancet (London, England). 378: 439-48. PMID 21664676 DOI: 10.1016/S0140-6736(11)60406-6 |
0.325 |
|
2011 |
Stack ML, Ozawa S, Bishai DM, Mirelman A, Tam Y, Niessen L, Walker DG, Levine OS. Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. Health Affairs (Project Hope). 30: 1021-8. PMID 21653952 DOI: 10.1377/Hlthaff.2011.0382 |
0.301 |
|
2011 |
Ozawa S, Stack ML, Bishai DM, Mirelman A, Friberg IK, Niessen L, Walker DG, Levine OS. During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved. Health Affairs (Project Hope). 30: 1010-20. PMID 21653951 DOI: 10.1377/Hlthaff.2011.0381 |
0.322 |
|
2011 |
Dagan R, Bhutta ZA, de Quadros CA, Garau J, Klugman KP, Khuri-Bulos N, Levine O, Saha SK, Sow S, Were F, Yang Y. The remaining challenge of pneumonia: the leading killer of children. The Pediatric Infectious Disease Journal. 30: 1-2. PMID 21076365 DOI: 10.1097/Inf.0B013E3182005389 |
0.328 |
|
2010 |
Dagan R, de Quadros CA, Garau J, Klugman KP, Khuri-Bulos N, Levine O, Sow S, Yang Y. Marking November 12, 2010 - World Pneumonia Day: where are we, where are vaccines? Human Vaccines. 6: 922-5. PMID 21045539 DOI: 10.4161/Hv.6.11.13599 |
0.352 |
|
2010 |
Fitzwater SP, Watt JP, Levine OS, Santosham M. Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries. Human Vaccines. 6: 810-8. PMID 20980793 DOI: 10.4161/Hv.6.10.13017 |
0.327 |
|
2010 |
Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. Plos Medicine. 7. PMID 20957191 DOI: 10.1371/Journal.Pmed.1000348 |
0.352 |
|
2010 |
Ramakrishnan M, Moïsi JC, Etame MM, Klugman KP, Feris JM, Levine OS. Invasive infections and sickle-cell disease - Authors' reply The Lancet Infectious Diseases. 10: 593-594. PMID 20797638 DOI: 10.1016/S1473-3099(10)70181-X |
0.609 |
|
2010 |
Moïsi JC, Kabuka J, Mitingi D, Levine OS, Scott JA. Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable? Vaccine. 28: 5725-30. PMID 20600489 DOI: 10.1016/J.Vaccine.2010.06.011 |
0.329 |
|
2010 |
Ramakrishnan M, Moïsi JC, Klugman KP, Iglesias JM, Grant LR, Mpoudi-Etame M, Levine OS. Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 10: 329-37. PMID 20417415 DOI: 10.1016/S1473-3099(10)70055-4 |
0.618 |
|
2010 |
Levine OS, Knoll MD, Jones A, Walker DG, Risko N, Gilani Z. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. Current Opinion in Infectious Diseases. 23: 236-41. PMID 20407316 DOI: 10.1097/Qco.0B013E328338C135 |
0.347 |
|
2009 |
Rehm SJ, Farley MM, File TM, Hall WJ, Hopkins R, Levine OS, Nichol KL, Nuorti P, Zimmerman RK, Schaffner W. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgraduate Medicine. 121: 101-5. PMID 19940420 DOI: 10.3810/pgm.2009.11.2069 |
0.335 |
|
2009 |
Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS. Sequelae due to bacterial meningitis among African children: a systematic literature review. Bmc Medicine. 7: 47. PMID 19751516 DOI: 10.1186/1741-7015-7-47 |
0.6 |
|
2009 |
Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K, Cherian T. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet (London, England). 374: 903-11. PMID 19748399 DOI: 10.1016/S0140-6736(09)61203-4 |
0.343 |
|
2009 |
O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet (London, England). 374: 893-902. PMID 19748398 DOI: 10.1016/S0140-6736(09)61204-6 |
0.313 |
|
2009 |
Knoll MD, Moïsi JC, Muhib FB, Wonodi CB, Lee EH, Grant L, Gilani Z, Anude CJ, O'Brien KL, Cherian T, Levine OS. Standardizing surveillance of pneumococcal disease. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: S37-48. PMID 19191618 DOI: 10.1086/596480 |
0.636 |
|
2008 |
Madhi SA, Levine OS, Hajjeh R, Mansoor OD, Cherian T. Vaccines to prevent pneumonia and improve child survival. Bulletin of the World Health Organization. 86: 365-72. PMID 18545739 DOI: 10.2471/BLT.07.044503 |
0.346 |
|
2007 |
Levine O, Cherian T. Do Indian children need pneumococcal vaccination? (Reply) [2] Indian Pediatrics. 44: 791-792. PMID 17998585 |
0.333 |
|
2007 |
Levine OS, Cherian T. Pneumococcal vaccination for Indian children. Indian Pediatrics. 44: 491-6. PMID 17684301 |
0.329 |
|
2007 |
Sinha A, Levine O, Knoll MD, Muhib F, Lieu TA. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet (London, England). 369: 389-96. PMID 17276779 DOI: 10.1016/S0140-6736(07)60195-0 |
0.402 |
|
2006 |
Dentinger CM, Hennessy TW, Bulkow LR, Reasonover AL, Romero-Steiner S, Holder PF, de Leon PG, Carlone GM, Parks DJ, Parkinson AJ, Singleton RJ, Levine OS, Butler JC. Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults. Human Vaccines. 2: 24-8. PMID 17012896 |
0.323 |
|
2006 |
Moïsi JC, Levine OS, Watt JP. Sensitivity of surveillance for Haemophilus influenzae Type b meningitis. The Pediatric Infectious Disease Journal. 25: 960. PMID 17006304 DOI: 10.1097/01.Inf.0000235748.52411.A9 |
0.566 |
|
2006 |
Garcia S, Levine OS, Cherian T, Gabastou JM, Andrus J. Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 19: 340-8. PMID 16805976 DOI: 10.1590/S1020-49892006000500007 |
0.352 |
|
2006 |
Baggett HC, Hennessy TW, Bulkow L, Romero-Steiner S, Hurlburt D, Holder P, Parkinson AJ, Singleton RJ, Levine O, Carlone GM, Butler JC. Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska. Clinical and Vaccine Immunology : Cvi. 13: 620-6. PMID 16760318 DOI: 10.1128/Cvi.00077-06 |
0.427 |
|
2005 |
Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet (London, England). 365: 1139-46. PMID 15794968 DOI: 10.1016/S0140-6736(05)71876-6 |
0.355 |
|
2004 |
Martin M, Casellas JM, Madhi SA, Urquhart TJ, Delport SD, Ferrero F, Chamany S, Dayan GH, Rose CE, Levine OS, Klugman KP, Feikin DR. Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. The Pediatric Infectious Disease Journal. 23: 842-7. PMID 15361724 DOI: 10.1097/01.Inf.0000137575.82874.0C |
0.334 |
|
2004 |
Feikin DR, Nelson CB, Watt JP, Mohsni E, Wenger JD, Levine OS. Rapid assessment tool for Haemophilus influenzae type b disease in developing countries. Emerging Infectious Diseases. 10: 1270-6. PMID 15324548 DOI: 10.3201/eid1007.030737 |
0.348 |
|
2003 |
Watt JP, Levine OS, Santosham M. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. The Journal of Pediatrics. 143: S163-87. PMID 14657805 DOI: 10.1067/S0022-3476(03)00576-6 |
0.353 |
|
2002 |
Lucher LA, Reeves M, Hennessy T, Levine OS, Popovic T, Rosenstein N, Parkinson AJ. Reemergence, in southwestern Alaska, of invasive Haemophilus influenzae type b disease due to strains indistinguishable from those isolated from vaccinated children. The Journal of Infectious Diseases. 186: 958-65. PMID 12232836 DOI: 10.1086/342595 |
0.302 |
|
2000 |
Gomez E, Peguero M, Sanchez J, Castellanos PL, Feris J, Peña C, Brudzinski-LaClaire L, Levine OS. Population-based surveillance for bacterial meningitis in the Dominican Republic: implications for control by vaccination. Epidemiology and Infection. 125: 549-54. PMID 11218205 DOI: 10.1017/S0950268800004830 |
0.365 |
|
2000 |
Millar EV, O'Brien KL, Levine OS, Kvamme S, Reid R, Santosham M. Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children. American Journal of Public Health. 90: 1550-4. PMID 11029987 DOI: 10.2105/Ajph.90.10.1550 |
0.384 |
|
2000 |
Singleton R, Bulkow LR, Levine OS, Butler JC, Hennessy TW, Parkinson A. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: The impact of persistent oropharyngeal carriage Journal of Pediatrics. 137: 313-320. PMID 10969253 DOI: 10.1067/mpd.2000.107843 |
0.375 |
|
1999 |
Levine OS, Lagos R, Muñoz A, Villaroel J, Alvarez AM, Abrego P, Levine MM. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b Pediatric Infectious Disease Journal. 18: 1060-1064. PMID 10608624 |
0.362 |
|
1999 |
Fiore AE, Levine OS, Elliott JA, Facklam RR, Butler JC. Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease Emerging Infectious Diseases. 5: 828-831. PMID 10603221 |
0.347 |
|
1999 |
Mulholland K, Levine O, Nohynek H, Greenwood BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries Epidemiologic Reviews. 21: 43-55. PMID 10520472 DOI: 10.1093/Oxfordjournals.Epirev.A017987 |
0.442 |
|
1999 |
Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, Perkins BA, Parkinson A. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. The Journal of Infectious Diseases. 179: 101-6. PMID 9841828 DOI: 10.1086/314569 |
0.362 |
|
1998 |
Levine OS, Schwartz B. The rationale for population-based surveillance for Haemophilus influenzae type b meningitis Pediatric Infectious Disease Journal. 17. PMID 9781762 DOI: 10.1097/00006454-199809001-00024 |
0.366 |
|
1998 |
Lagos R, Levine OS, Avendaño A, Horwitz I, Levine MM. The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: A framework for evaluating new vaccines in newly industrializing countries Pediatric Infectious Disease Journal. 17. PMID 9781748 DOI: 10.1097/00006454-199809001-00010 |
0.339 |
|
1998 |
Levine OS, Schwartz B, Pierce N, Kane M. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions. The Pediatric Infectious Disease Journal. 17: S95-113. PMID 9781741 DOI: 10.1097/00006454-199809001-00003 |
0.308 |
|
1998 |
Gómez E, Moore A, Sánchez J, Kool J, Castellanos PL, Feris JM, Kolczak M, Levine OS. The epidemiology of Haemophilus influenzae type b carriage among infants and young children in Santo Domingo, Dominican Republic Pediatric Infectious Disease Journal. 17: 782-786. PMID 9779761 DOI: 10.1097/00006454-199809000-00006 |
0.333 |
|
1998 |
Levine MM, Lagos R, Levine OS, Heitmann I, Enriquez N, Eugenia M, Alvarez AM, Mayorga C, Reyes A. Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country Pediatric Infectious Disease Journal. 17: 287-293. PMID 9576382 DOI: 10.1097/00006454-199804000-00005 |
0.327 |
|
1998 |
Rosenstein N, Levine O, Taylor JP, Evans D, Plikaytis BD, Wenger JD, Perkins BA. Efficacy of meningococcal vaccine and barriers to vaccination. Jama. 279: 435-9. PMID 9466635 DOI: 10.1001/Jama.279.6.435 |
0.396 |
|
1997 |
Levine MM, Levine OS. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use Lancet. 350: 1386-1392. PMID 9365466 DOI: 10.1016/S0140-6736(97)03253-4 |
0.317 |
|
1997 |
Galil K, Singleton R, Levine O, Fitzgerald M, Ajello Q, Bulkow L, Parkinson A. High prevalence of Haemophilus influenzae type b (Hib) carriage among alaska natives despite widespread use of hib conjugate vaccine Clinical Infectious Diseases. 25: 433. |
0.369 |
|
1996 |
Lagos R, Horwitz I, Toro J, Martin OS, Abrego P, Bustamante C, Wasserman SS, Levine OS, Levine MM. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: Practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections Pediatric Infectious Disease Journal. 15: 216-222. PMID 8852909 DOI: 10.1097/00006454-199603000-00008 |
0.33 |
|
Show low-probability matches. |